HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Seminara Selected Research

Raxofelast

7/2005Lipid peroxidation inhibition by raxofelast improves angiogenesis and wound healing in experimental burn wounds.
4/2005Protective effects of antioxidant raxofelast in alcohol-induced liver disease in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Seminara Research Topics

Disease

3Wounds and Injuries (Trauma)
07/2005 - 04/2003
3Pancreatitis
10/2004 - 04/2003
2Burns
07/2005 - 04/2003
1Low Back Pain (Lumbago)
01/2018
1Pain (Aches)
01/2018
1Neuralgia (Stump Neuralgia)
01/2018
1Radiculopathy (Radiculopathy, Cervical)
01/2018
1Drug-Related Side Effects and Adverse Reactions
01/2017
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
03/2006
1Fatigue
03/2006
1Necrosis
03/2006
1Wasting Syndrome (Wasting Disease)
03/2006
1Cardiotoxicity
10/2005
1Liver Diseases (Liver Disease)
04/2005
1Hyperplasia
02/2005
1Brain Injuries (Brain Injury)
07/2004
1Reperfusion Injury
08/2003
1Infarction (Infarctions)
08/2003
1Myocardial Ischemia (Ischemic Heart Diseases)
08/2003
1Body Weight (Weight, Body)
04/2003
1Shock
06/2002
1Hypotension (Low Blood Pressure)
06/2002
1Septic Shock (Toxic Shock Syndrome)
06/2002

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
03/2006 - 06/2002
5NF-kappa B (NF-kB)IBA
03/2006 - 06/2002
5Messenger RNA (mRNA)IBA
02/2005 - 06/2002
3IRFI 042IBA
03/2006 - 06/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2006 - 06/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2005 - 04/2003
3CeruletideIBA
10/2004 - 04/2003
2Vitamin EFDA LinkGeneric
10/2005 - 06/2002
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2005 - 04/2003
2NitritesIBA
07/2005 - 04/2003
2RaxofelastIBA
07/2005 - 04/2005
2AntioxidantsIBA
04/2005 - 06/2002
2JNK Mitogen-Activated Protein KinasesIBA
02/2005 - 10/2004
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2005 - 08/2003
2Mitogen-Activated Protein Kinase 3IBA
02/2005 - 10/2004
1AmidesIBA
01/2018
1codeine drug combination acetaminophenIBA
01/2018
1TabletsIBA
01/2018
1Ethanol (Ethyl Alcohol)IBA
01/2018
1Pharmaceutical PreparationsIBA
01/2017
1Cocaine (Cocaine HCl)IBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
03/2006
1DystrophinIBA
03/2006
1Monensin (Coban)IBA
10/2005
1Glutathione (Reduced Glutathione)IBA
07/2005
1lipid peroxidation inhibitorIBA
07/2005
1Mitogen-Activated Protein KinasesIBA
02/2005
1Phosphotransferases (Kinase)IBA
02/2005
1Dihydrotachysterol (AT 10)IBA
02/2005
1pyrazolanthroneIBA
10/2004
1SecretagoguesIBA
10/2004
1ErythropoietinFDA Link
09/2004
1Interleukin-1beta (Interleukin 1 beta)IBA
07/2004
1salicylhydroxamic acid (SHAM)IBA
07/2004
1Kainic Acid (Kainate)IBA
07/2004
1Pancreatic Elastase (Elastase)IBA
08/2003
1NF-KappaB Inhibitor alphaIBA
08/2003
1NitratesIBA
04/2003
1EnzymesIBA
04/2003
1beta-Galactosidase (Lactaid)IBA
04/2003
1ImmunosorbentsIBA
04/2003
1LipopolysaccharidesIBA
06/2002
1EndotoxinsIBA
06/2002

Therapy/Procedure

1Therapeutics
01/2017
1Injections
10/2004